Edition:
United Kingdom

Profile: Natco Pharma Ltd (NATP.NS)

NATP.NS on National Stock Exchange of India

510.20INR
24 May 2019
Change (% chg)

Rs-1.35 (-0.26%)
Prev Close
Rs511.55
Open
Rs512.00
Day's High
Rs516.00
Day's Low
Rs507.70
Volume
153,699
Avg. Vol
224,177
52-wk High
Rs848.30
52-wk Low
Rs507.70

Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.

Company Address

Natco Pharma Ltd

Natco House, Road No 2, Banjara
HYDERABAD     500034
P: +9140.23547532
F: +9140.23545298

Company Web Links